Too much of anything can be bad, and the consequence of too much of drugs is something we are all familiar with. Not all of us have tried these drugs, but cinema has shown us the most graphic and ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

A 59-year-old Ridgetown woman faces a trafficking charge after a drug seizure Tuesday night. Approximately $36,000 worth of suspected cocaine and oxycodone were seized for analysis after the raid ...

Biologics are drugs made from complex molecules manufactured using living microorganisms, plant, or animal cells. Many are produced using advanced biotechnology techniques. Biologics are sometimes ...

There is growing awareness of the problems caused by the use of a fast-acting drug called ketamine. Often referred to as K or ket, it was made a class B drug in the UK in 2014 and is illegal to ...

Harry Sumnall receives funding from public grant awarding bodies for alcohol and other drugs research, and fees from (international) not-for-profit organisations and government departments for ...

The Central Drug Standards Control Organisation (CDSCO) has flagged more than 50 drugs for common conditions like high blood pressure and acid reflux as substandard. This includes batches from ...

India's drug regulator has identified 53 drugs, including supplements and medications for diabetes and high blood pressure, as 'Not of Standard Quality.' These drugs are produced by several ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...

A team has designed a new drug against malaria and identified its mechanism of action. In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent ...

Joseph Janes does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...